Toxic brain ‘waste’ linked to dementia and ALS in new University of Manchester study

University of Manchester scientists have identified unusually high levels of the common body waste product urea in the brains of people with frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), suggesting that a failure to clear this ‘toxic waste’ could be driving these incurable neurodegenerative diseases.

The research¹ helps explain why nerve cells die in FTD and ALS and could guide the development of new treatments.

Urea build-up discovered in FTD and ALS brains

In this new study, researchers measured urea — a waste chemical normally removed from the body in urine — in different regions of the brain using highly sensitive laboratory techniques. They compared brain tissue from people who had FTD or ALS with tissue from people without neurological disease, all of whom had donated their bodies to scientific research after death.

The team found that urea levels were significantly higher in the brains of people with FTD and ALS than in those without these conditions. In FTD, the urea build-up was detected not only in the most damaged brain regions but also in areas that appeared relatively spared. In ALS, elevated urea was mainly concentrated in regions that control movement.

Shared mechanism across multiple dementias

The University of Manchester group had previously reported similar ‘toxic waste’ accumulation in five other dementias, including Alzheimer’s disease and Parkinson’s-related dementia. This new work is the first to confirm the same phenomenon in FTD and ALS.

The findings add to growing evidence that several major brain diseases may share a common problem in how the brain handles and clears waste products. This suggests that, rather than being entirely separate conditions with unrelated causes, dementias and motor neuron diseases could be linked by a shared vulnerability in waste clearance pathways.

What are frontotemporal dementia and amyotrophic lateral sclerosis?

FTD is the second most common form of early-onset dementia and typically affects people under the age of 65. It targets areas of the brain involved in behavior and personality, leading to changes in social conduct, decision-making and emotional responses. FTD occurs at a rate of around 15.1 cases per 100,000 people each year.

ALS, or motor neuron disease, is rarer, with about 2.1 new cases per 100,000 people annually. ALS attacks the nerve cells that control voluntary movement, causing progressive muscle weakness, difficulty speaking and swallowing, and ultimately problems with breathing. Both FTD and ALS are currently incurable and often fatal.

Despite their different symptoms, the two conditions are closely linked. Studies suggest that up to 15% of people with ALS also develop FTD, and around half of ALS patients show some degree of cognitive impairment. Scientists also know that FTD and ALS share key biological features, but the exact processes that drive these diseases remain poorly understood.

How toxic waste may damage nerve cells

The new results indicate that the brain may struggle to remove urea and possibly other harmful substances in FTD and ALS. Over time, this build-up of waste could poison nerve cells, disrupt normal brain function and accelerate disease progression.

By mapping where urea accumulates in the brain, the researchers showed that waste build-up in FTD is widespread, affecting both heavily damaged and relatively preserved regions. In ALS, the pattern is more focused, with the highest urea levels in motor control areas that are known to degenerate in the disease.

These patterns support the idea that impaired waste clearance is not just a side effect of cell death but may be an important driver of neurodegeneration.

Towards new treatments for neurodegenerative disease

The study highlights waste clearance as a promising target for future therapies. If scientists can understand why urea accumulates in the brain and how to remove it more effectively, they may be able to slow or halt the progression of FTD, ALS and other dementias.

“This is exciting because it suggests we might be looking at a common problem underlying several different brain diseases, rather than separate conditions with completely different causes,” said Dr. Sasha Philbert, the study’s lead author from The University of Manchester. “If we can work out why this waste is building up and how to clear it, we may be able to slow or even stop these diseases, opening the door to new treatments for conditions that currently have very few options.”

References

1. Philbert SA, Church SJ, Unwin RD, Cooper GJS, Elevated urea levels in human frontotemporal dementia and amyotrophic lateral sclerosis post-mortem brain tissue: evidence of a multi-dementia pathogenic mechanism, Molecular Omics, Volume 22, Issue 4, July 2026, https://doi.org/10.1093/molecular-omics/aaiag019

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>